Condom bill on hold
This article was originally published in The Tan Sheet
Executive Summary
California state Sen. Jim Battin (R) suspends bill SB 977, which would require condom warning labels alerting consumers about potential danger of contracting human papilloma virus. Battin pulled legislation July 12 after facing opposition in Assembly Health Committee; bill previously passed Senate by unanimous vote. Concerns, primarily voiced by Planned Parenthood, suggested consumers would not read the label and would be discouraged from condom use if they did. The bill, first introduced Feb. 23, will be held in the Health Committee and reintroduced next session with amended language. A recent NIH study concluded evidence is insufficient to evaluate effectiveness of condoms in preventing spread of HPV (1"The Tan Sheet" July 23, p. 13)
You may also be interested in...
Condom HIV Protection Supported By Panel, Other STDs Inconclusive
Latex condom use lowers the risk of acquiring HIV and gonorrhea, but study data on condoms' effectiveness at reducing the risk of other sexually transmitted diseases is inconclusive, according to a recent National Institutes of Health report.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands